Accelerate to discover
Related topics
IncuCyte webinar recording: CAR T-cell therapy, frontiers in cancer Immunotherapy
Jan 11, 2019
The success of immune checkpoint blockade adds new therapeutic category to Cancers are the most heterogenous group of...
Bioflux webinar: Blockade of CD62L inhibits CLL cell interaction with vascular endothelium
Nov 22, 2018
CD62L (L-selectin) is a key adhesion molecule that promotes cell tethering and rolling along the vascular endothelium...
Xcell Bio webinar: AVATAR system, to control cell state to get better cells, fast
Oct 30, 2018
Dr. Schneider will show examples of data from customers who have incorporated pressure along with oxygen to recreate...
Webinar Tuning Microenvironment to Control Cells for Improved Disease Modeling & Immunotherapy Work
Jul 16, 2018
The company producing Avatar, xCELL biosciences have organized a webinar about the tuning of microenvironment to...
How microCT can provide insight into dynamic disease processes webinar
Jun 19, 2018
Professor Vande Velde will describe how high-field MRI and low dose microCT complement each other; where microCT gives...
Photoacoustic Imaging of placental oxygenation
May 16, 2018
Watch the new webinar about photoacoustick imaging presented by Dr. Liliya M. Yamaleyeva, Assistant Professor in the...
BioFlux webinar: Introducing new plates and capabilities of BioFlux microfluidic system
May 13, 2018
BioFlux biofilm assays can now be performed on the popular catheter material polydimethylsiloxane (PDMS). Silicone...
IncuCyte webinar: advanced 3D cell models providing greater biological insight
Apr 30, 2018
Cancer researchers are increasingly turning to more complex live-cell assay systems that recapitulate key aspects of...
Jun 13, 2016
Friday, June 17th, 2016, 5 pm CEST.
High content functional assays that can monitor parameters such as membrane integrity, cytokine release, and more, are critical to understanding target cell response to immunotherapies and allow for rational design of improved therapies.
This webinar will highlight:
- Challenges posed by current methods to screen the efficacy of immunotherapies.
- The need for high content robust tools to evaluate current immunotherapeutic approaches such as adoptive cell therapy, checkpoint blockade etc.
- The ability of the iQue Screener platform to acquire single-cell data on multiple biological readouts in a quantitative, high-throughput fashion and better understand functional efficacy of immuno-oncology therapies.
Get more info
Brand profile
IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.
More info at:
www.intellicyt.com/
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
